在多发性肌痛类风湿症患者中重复进行短期皮质激素检测
Tobias Gaster1,2, Andreas Wiggers Nielsen1,2,3, Simon Bøggild Hansen2,4
1Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark.
Rheumatology (Oxford, England)
|November 20, 2025
概括
葡萄糖皮质类药物诱导的上腺功能衰竭 (GIAI) 在多发性肌痛性风湿症 (PMR) 患者中很常见,但在停止治疗后通常可逆. 治疗后,上腺功能可能无法完全恢复到基线水平.
科学领域:
- 内分泌学 在内分泌学.
- 类风湿病学 类风湿病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 多发性肌痛性风湿症 (PMR) 通常用葡萄糖皮质类药物 (GCs) 治疗.
- GC治疗可能导致上腺功能不充分.
- 在PMR患者中,GC诱导的上腺功能衰竭 (GIAI) 的患病率和可逆性需要进一步调查.
研究的目的:
- 为了研究PMR患者的上腺功能.
- 为了确定在GC治疗的前18个月内GIAI的患病率.
- 评估GC停止后GIAI的可逆性.
主要方法:
- 新诊断的PMR患者在多个时间点进行了短暂的皮质otropin测试.
- 在GC治疗之前进行了测试,并在10周,6个月,12个月和18个月后进行了测试.
- GIAI被定义为刺激的血清皮质醇水平低于420nmol/l.
主要成果:
- 刺激皮质醇水平在第6个月显著下降,与GC剂量呈反向关系.
- 在第6个月,GIAI的患病率达到25%的峰值,大多数病例在12个月内消失.
- 在GC停止后,上腺功能并不总是达到治疗前的水平.
结论:
- 在接受GC治疗的PMR患者中,GIAI是频繁但可逆的.
- 这些发现支持考虑在PMR患者的压力期间增加GC剂量.
- 在PMR中计划GC停止后,用于GIAI诊断的例行短期皮质激素检测目前没有数据证明是合理的.
相关概念视频
Myasthenia Gravis: Diagnostic Tests
1.9K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.9K
Myocarditis II: Clinical Features and Diagnostic Tests
242
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
242
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
460
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
460
Cardiomyopathy IV: Restrictive Cardiomyopathy
432
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
432
Pericarditis II: Clinical Features and Diagnostic Tests
270
Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
270


